Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/08/2009WO2009088738A3 Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
10/08/2009WO2009087091A8 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy
10/08/2009WO2009077874A3 A pharmaceutical composition for treating esophageal cancer
10/08/2009WO2009065604A3 Pharmaceutical composition comprising glucosamine sulfate, chondroitine sulfate and ibuprofene
10/08/2009WO2009064681A3 Liquid compositions comprising valsartan
10/08/2009WO2009042435A8 Pyridin-2 -yl-amino-i, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
10/08/2009WO2009027056A4 Antioxidant and paramagnetic heparin-nitroxide derivatives
10/08/2009WO2009026178A3 High concentration local anesthetic formulations
10/08/2009WO2009019295A3 Phenyl- and benzylthiazolylpiperazine derivatives for the treatment of neurodegenerative diseases
10/08/2009WO2008118552A9 Use of ranolazine for the treatment of cardiovascular diseases
10/08/2009WO2008112022A8 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
10/08/2009WO2008108286A9 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
10/08/2009WO2008107910A3 Use of caralluma extracts in the inhibition of adipogenesis and a method of inhibition for the same
10/08/2009WO2008101724A8 Use of riboflavin in the treatment of hypertension
10/08/2009WO2008101412A8 The use of epimedium flavones and effective components thereof for the preparation of medicaments of promoting proliferations and differentiations of nerve cells
10/08/2009WO2008080844A9 Azaspiro derivatives
10/08/2009WO2008072799A9 Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof
10/08/2009WO2008062437A3 Process for the preparation of sevelamer hydrochloride and formulation thereof
10/08/2009WO2007124849A3 Inhibitors of the task-1 and task-3 ion channel
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090255003 Diagnostic and therapeutic target SLC39A11 proteins for neurodegenerative diseases
10/08/2009US20090255001 Parkinson's Disease-Related Gene GRK5 and Uses Thereof
10/08/2009US20090253950 Radioactive member and method of making
10/08/2009US20090253933 Nateglinide crystals
10/08/2009US20090253911 New Compounds Useful for the Synthesis of S- and R-Omeprazole and a Process for Their Preparation
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253807 Aqueous suspension preparations
10/08/2009US20090253804 Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes
10/08/2009US20090253803 Memantine protects inflammation-related degeneration of dopamine neurons through inhibition of over-activated microglia and release of neurotrophic factors from astroglia
10/08/2009US20090253802 Therapeutic Agent for Treating liver Disease Containing 2-Amino-1,3-Propanediol Derivative as Active Ingredient, and Method for Treating Liver Disease
10/08/2009US20090253801 Novel Antiarrhythmic Drug Formulations
10/08/2009US20090253799 Divalent hydrazide compound conjugates for inhibiting cystic fibrosis transmembrane conductance regulator
10/08/2009US20090253798 Colchicine solid complex; methods of making; and methods of use thereof
10/08/2009US20090253797 Creatine oral supplementation using creatine hydrochloride salt
10/08/2009US20090253796 Method for treating vascular disease
10/08/2009US20090253795 Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibiton of pain and inflammation
10/08/2009US20090253794 Fibroblast Activator, Collagen Production Promoter, Collagen Contraction Promoter, Hyaluronic Acid Production Promoter, ATP Production Promoter, Melanin Formation Inhibitor, and Agent for External Application to the Skin
10/08/2009US20090253793 Composition and method for binding acetaldehyde in stomach
10/08/2009US20090253792 Active agent delivery systems and methods for protecting and administering active agents
10/08/2009US20090253791 Compositions and Methods For Preventing Or Treating Inflammatory Bowel Disease
10/08/2009US20090253789 Preventive/Remedy for Arteriosclerotic Disease and Method of Evaluating Therapeutic Procedure
10/08/2009US20090253788 Combinations of adapalene and benzoyl peroxide for treating acne lesions
10/08/2009US20090253787 Short-acting sedative hypnotic agents for anesthesia and sedation
10/08/2009US20090253786 Synthesis, anti-allergic, anti-asthmatic and anti-inflammatory activities of CEE-1 and CEE-2
10/08/2009US20090253785 Bactericide composition
10/08/2009US20090253783 Production of Delta 9 Tetrahydrocannabinol
10/08/2009US20090253782 Compounds for Enhancing Arginase Activity and Methods of USe Thereof
10/08/2009US20090253781 Therapeutic compositions
10/08/2009US20090253780 COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER
10/08/2009US20090253779 Expression of Rbap48 in Memory and Aging and Methods Related Thereto
10/08/2009US20090253778 DNA composition against tumor stromal antigen FAP and methods of use thereof
10/08/2009US20090253777 Methods of diagnosing and treating hyperproliferative disorders
10/08/2009US20090253776 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
10/08/2009US20090253775 Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis
10/08/2009US20090253774 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
10/08/2009US20090253773 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
10/08/2009US20090253772 RNA INTERFERENCE MEDIATED INHIBITION OF CXCR4 GENE EXPRESSION USING SHORT INTERFERING NUCELEIC ACID (siNA)
10/08/2009US20090253771 Inhibition of gliotoxin
10/08/2009US20090253770 Target gene mimitin of myc
10/08/2009US20090253769 Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders
10/08/2009US20090253768 Therapeutic compounds for diseases and disorders
10/08/2009US20090253767 Aminoindazolylurea derivatives
10/08/2009US20090253766 Thiophene derivatives as factor xia inhibitors
10/08/2009US20090253765 Angiogenesis Inhibitor Containing Amine Derivative as Active Ingredient
10/08/2009US20090253764 Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
10/08/2009US20090253762 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
10/08/2009US20090253761 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
10/08/2009US20090253760 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
10/08/2009US20090253759 Tetralin analogs having sphingosine 1-phosphate agonist activity
10/08/2009US20090253758 Selective androgen receptor modulators
10/08/2009US20090253756 Indole Amide Derivatives as EP4 Receptor Antagonists
10/08/2009US20090253754 Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine
10/08/2009US20090253753 Therapeutic Use of Acylaminothiazole Derivatives
10/08/2009US20090253752 Combination of dpp-iv inhibitor, ppar antidiabetic and metmorfin
10/08/2009US20090253751 Hydrazide compound and thrombopoietin receptor activator
10/08/2009US20090253750 3-indazolyl-4-pyridylisothiazoles
10/08/2009US20090253748 Process for the preparation of pleuromutilins
10/08/2009US20090253747 Remedy for sleep disturbance
10/08/2009US20090253746 Synthesis and Preparations of Intermediates and New Polymorphs Thereof Useful For The Preparation Of Donepezil Hydrochlcoride
10/08/2009US20090253745 Modulators of ocular oxidative stress
10/08/2009US20090253744 Acylated piperidine derivatives as melanocortin-4 receptor modulators
10/08/2009US20090253743 Compositions of tolperisone
10/08/2009US20090253742 Marasmius androsaceus l.es fr extract, piperidone derivative, and their use for the preparation of antihypertensives
10/08/2009US20090253741 Alkene piperidine derivatives as antiviral agents
10/08/2009US20090253740 Substituted n-bicyclicalkyl bicycliccarboxyamide compounds
10/08/2009US20090253739 Amine Derivatives
10/08/2009US20090253738 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/08/2009US20090253737 Certain chemical entities, compositions, and methods
10/08/2009US20090253736 Azaindole derivatives as cftr modulators
10/08/2009US20090253735 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
10/08/2009US20090253734 Inhibitors of akt activity
10/08/2009US20090253733 Rapamycin carbonate esters
10/08/2009US20090253732 Production Of Polyketides And Other Natural Products
10/08/2009US20090253731 Method of identifying therapeutic agents
10/08/2009US20090253730 Method and composition for deterring abuse of opioid containing dosage forms
10/08/2009US20090253729 Analgesic Agent
10/08/2009US20090253728 Methods and Compositions for Treating Nociceptive Pain
10/08/2009US20090253727 Nociceptin analogs
10/08/2009US20090253726 Tri-, tetra-substituted-3-aminopyrrolidine derivative
10/08/2009US20090253725 ACETYL CoA CARBOXYLASE INHIBITORS
1 ... 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 ... 7860